These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24840660)

  • 1. Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis.
    Waltmann MD; Basford JE; Konaniah ES; Weintraub NL; Hui DY
    Biochim Biophys Acta; 2014 Sep; 1842(9):1395-405. PubMed ID: 24840660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoER2 (Apolipoprotein E Receptor-2) Deficiency Accelerates Smooth Muscle Cell Senescence via Cytokinesis Impairment and Promotes Fibrotic Neointima After Vascular Injury.
    Komaravolu RK; Waltmann MD; Konaniah E; Jaeschke A; Hui DY
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2132-2144. PubMed ID: 31412739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deacetylation Suppresses Aging-Associated Atherosclerosis and Hypercholesterolemia.
    Zahr T; Liu L; Chan M; Zhou Q; Cai B; He Y; Aaron N; Accili D; Sun L; Qiang L
    Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):30-44. PubMed ID: 36453279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.
    Thorp E; Kuriakose G; Shah YM; Gonzalez FJ; Tabas I
    Circulation; 2007 Nov; 116(19):2182-90. PubMed ID: 17967777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
    Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
    J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein-induced expression of ABCA1 in blood monocytes precedes coronary atherosclerosis and is associated with plaque complexity in hypercholesterolemic pigs.
    Geeraert B; De Keyzer D; Davey PC; Crombé F; Benhabilès N; Holvoet P
    J Thromb Haemost; 2007 Dec; 5(12):2529-36. PubMed ID: 17922810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice.
    Qu A; Shah YM; Manna SK; Gonzalez FJ
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):65-73. PubMed ID: 22015658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Necrosis and Content of Apoptotic M1 Macrophages in Advanced Atherosclerotic Plaques of Mice With Macrophage-Specific Loss of Trpc3.
    Solanki S; Dube PR; Birnbaumer L; Vazquez G
    Sci Rep; 2017 Feb; 7():42526. PubMed ID: 28186192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.
    Oppi S; Nusser-Stein S; Blyszczuk P; Wang X; Jomard A; Marzolla V; Yang K; Velagapudi S; Ward LJ; Yuan XM; Geiger MA; Guillaumon AT; Othman A; Hornemann T; Rancic Z; Ryu D; Oosterveer MH; Osto E; Lüscher TF; Stein S
    Eur Heart J; 2020 Mar; 41(9):995-1005. PubMed ID: 31529020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.
    Babaev VR; Runner RP; Fan D; Ding L; Zhang Y; Tao H; Erbay E; Görgün CZ; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1283-90. PubMed ID: 21474828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different sensitivity to diet-induced hyperinsulinemia and hyperglycemia between mice with global or bone marrow-specific apoE receptor-2 deficiency.
    Wolfkiel PR; Haller AM; Kirby J; Jaeschke A; Hui DY
    Am J Physiol Regul Integr Comp Physiol; 2023 Jul; 325(1):R55-R68. PubMed ID: 37212552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
    Gurzeler E; Ruotsalainen AK; Laine A; Valkama T; Kettunen S; Laakso M; Ylä-Herttuala S
    PLoS One; 2021; 16(11):e0258408. PubMed ID: 34767557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
    Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
    Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinexin β Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor κB Inflammatory Axis.
    Guan H; Cheng WL; Guo J; Chao ML; Zhang Y; Gong J; Zhu XY; She ZG; Huang Z; Li H
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28209562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.
    Zhou MS; Chadipiralla K; Mendez AJ; Jaimes EA; Silverstein RL; Webster K; Raij L
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H563-74. PubMed ID: 23748423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs.
    Holvoet P; Vanhaverbeke M; Geeraert B; De Keyzer D; Hulsmans M; Janssens S
    PLoS One; 2017; 12(1):e0170307. PubMed ID: 28122051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.